tDCS and Aphasia Therapy in the Acute Phase After Stroke


Phase 2 Results N/A

Summary of Purpose

This study evaluates the neuromodulatory effect of combined tDCS and aphasia therapy in patients in the acute stage after stroke. Half of the participants will receive aphasia therapy and tDCS, the other half will receive aphasia therapy and sham-tDCS. Trial Stopped: Difficult patient recruitment

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 March 2018.

2 Oct 2017 5 Sep 2017 30 Mar 2018 30 Mar 2018 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available